Insulin Resistance Questionnaire

 

Not all products listed would be needed in all cases. Products are listed in sequence of importance.

 

Presence of associated diseases or biochemical abnormalities

Hyperglycemia:

  • Type 2 diabetes
  • Impaired glucose tolerance (IGT) 4
  • Gestational diabetes 3
  • Impaired fasting glucose (110-125 mg/dl) 2

Hypertriglyceridemia (fasting):

  • Triglycerides > 150 mg/dl/HDL cholesterol < 35 3
  • Triglycerides > 150 mg/dl 2
  • Triglycerides > 100-150 mg/dl

Essential hypertension:

  • Blood pressure > 140/90 mmHg 2
  • Blood pressure > 125-140/85-90 mmHg

Polycystic ovaries 4

Premature coronary heart disease (under age 60 years) 3

Uric acid (> 8 mg/dl) 2

Family history (first-degree relatives)

Type 2 diabetes or impaired glucose tolerance

Essential hypertension (under age 60 years) 2

Hypertriglyceridemia 3

Premature coronary heart disease (under age 60 years) 2

Presence of predisposing factors

Low birth weight (< 2.5 kg) 2

Inactivity (< 90 min aerobic exercise/week) 2

Evidence of mild obesity or central adiposity (maximum 4 points)

Weight gain: > 4, 8, or 12 kg after age 18 years (W*), 21 years (M*) -3

BMI: 23-25, 25-27 kg/m2 , 2

Waist (inches):

  • 28-30, > 30 (W) , 2
  • 34-36, > 36 (M) , 2

Ethnic group at high risk* -3

MONW individual equals a score of 7 points or greater. Scheme applies to men and women aged 20-55 years with a BMI < 27

kg/m2. A similar scheme with minor modifications could be applied to individuals with a BMI > 27 kg/m2. In the latter, additional points would be given for greater increases in the obesity-related parameters.

*W, women; M, men. Ethnic group at high risk includes (in order of ascending risk) black women, Japanese-Americans, Latinos, Melanesians, Polynesians (including New Zealand Maoris), Indians, Australian aborigines, Micronesians (including Naruans) and some American Indian tribes. The risk is especially high in those who have adopted a Western lifestyle.

Reprinted with permission from the publisher of "The Metabolically Obese, Normal-Weight Individual Revisited," by Neil Ruderman, Donald Chisholm, Xavier Pi-Sunyer, and Stephen Schneider, Diabetes. May, 1998; vol 47, p. 704. Copyright 1998

by the American Diabetes Association.

 

Reprinted with permission from the publisher of "The Metabolically Obese, Normal-Weight Individual Revisited," by Neil Ruderman, Donald Chisholm, Xavier Pi-Sunyer, and Stephen Schneider, Diabetes. May, 1998; vol 47, p. 704. Copyright 1998

by the American Diabetes Association.